Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure

Current Cardiology Reports

Volumn 1, Issue 1, 1999, Pages 31-

  LeJemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; PIPERANOMETOZINE; QUINOLINE DERIVATIVE;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; HUMAN; MORTALITY; REVIEW; SURVIVAL;

CARDIOTONIC AGENTS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HUMANS; QUINOLINES; SURVIVAL ANALYSIS;

EID: 0033122876     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-999-0038-4     Document Type: Review

References (3)

1. Cohn JN, Goldstein SO, Greenberg BH, et al.: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med 1998, 339:1810-1816.
2. Stevenson LW: Inotropic therapy for heart failure [editorial]. N Engl J Med 1998, 339:1848-1850.
3. Eichhorn EJ, Heesch CM, Risser RC, et al.: Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol 1995, 25:154-162.